By | March 18, 2022

In the News: $26 Billion in Funding to Go to Communities Around the Country After Johnson & Johnson, Drug Distributors Finalize Opioid Settlement

In late February, the nation’s three largest drug distributors — AmerisourceBergen, Cardinal Health and McKesson — and drugmaker Johnson & Johnson agreed to finalize a $26 billion opioid settlement with states and… Read More

By | March 18, 2022

FDA Orders Philips Respironics to Improve Its Communications Regarding June 2021 Recall of Sleep Apnea Machines

On March 10, the U.S. Food and Drug Administration (FDA) issued an order to Philips Respironics — maker of ventilators, CPAP and BiPAP machines — to notify all patients about their recall… Read More

By | May 22, 2020

Cosmetic Talc Allegations Involving Mesothelioma Continue to Rise as J&J Stops Selling Talc Baby Powder Product

Shareholder James Kramer weighs in on talc litigation during Perrin webinar Talcum powder and other talc-based products sit at the heart of over 9,000 lawsuits currently awaiting trial. But how did it… Read More

By | August 31, 2019

In Landmark Trial, Johnson & Johnson Ordered to Pay $572 Million for Its Role in Opioid Epidemic

In a landmark judgement, Oklahoma judge Thad Balkman ruled on Monday, Aug. 26, that Johnson & Johnson is liable for playing a large role in sparking the state’s opioid crisis through its… Read More

By | November 22, 2016

FDA Mandates Boxed Warning, Patient Checklist for Essure

The U.S. Food and Drug Administration (FDA) recommended on Nov. 15 a boxed warning and a patient checklist that highlights possible adverse events associated with the use of Essure, Bayer’s permanent contraception… Read More

By | October 26, 2015

The History of Risperdal in the Pharmaceutical Marketplace

Also known by the generic name risperidone, Risperdal is a powerful, anti-psychotic medication prescribed to treat schizophrenia, autism and bipolar disorders in adults. Its manufacturer, Johnson & Johnson (J&J), has recently been making… Read More

By | February 5, 2014

Simmons Hanly Conroy Files First Testosterone Treatment Lawsuits, Bloomberg Reports

Yesterday, attorneys at the firm filed the first testosterone treatment lawsuit on behalf of five men against Abbott Laboratoes and AbbVie, Inc. The men range in age from 50 to 63 and… Read More

By | June 7, 2013

DA Approves Liptruzet – Merck’s Combination of Zetia and Lipitor

The Food and Drug Administration recently approved a new cholesterol-lowering medication called Liptruzet. This drug combines two already existing medications. The first, Zetia, goes by the generic name ezetimibe and works by… Read More

By | December 23, 2010

Looking Back, Moving Forward

For me, December and the holiday season has always been a time to reflect on the past year. A time to remember the challenges we’ve overcome; the projects we’ve spearheaded; and the… Read More

Topics

PAST ARTICLES